bioMérieux Opens a Molecular and Genomic Innovation Center at the Navy Yard in Philadelphia
The new 32,000 sq. ft. facility is home to the xPRO™ Program, which has rapidly changed the landscape of food safety diagnostic capabilities by partnering directly with industry leaders to address unmet needs to streamline operational efficiencies and further public health. bioMérieux’s global leadership team was on-site for the ribbon cutting event, as Philadelphia continues to fortify its reputation as a hotbed of innovation in Life Sciences across North America.
“We couldn’t be more excited to deepen our roots in Philadelphia, which has long supported our organization through its commitment to fostering an entrepreneurial environment that promotes innovation and collaboration,” said Ben Pascal, global head of the xPRO™ Program, “As the innovation leader in the market and with our focus on maintaining a culture of entrepreneurship, the new site bolsters our ability to rapidly respond and develop breakthrough innovations that change the paradigm for global food safety.”
bioMérieux selected to open the site at the Navy Yard, which serves the region as an innovation Life Sciences hub focused on research and development, commercialization and manufacturing, and boasts a roster of regional and global companies currently occupying more than one-million square feet of life sciences and advanced manufacturing space. The opening of bioMérieux at the Navy Yard strengthens the sites reputation as a foremost innovation hub across the US.
“The opening of the Molecular and Genomic Innovation Center at the Navy Yard is an important milestone in bioMérieux’s storied legacy, as we continue to provide game changing diagnostic solutions that solve the food safety industry’s most persistent and urgent challenges,” said Miguel Villa, Sr. Vice President, Industrial Applications, Americas, and xPRO™ sponsor, “This facility – in conjunction with our unique Augmented Diagnostics approach to food safety – allows us to continue redefining the role and capabilities of diagnostic testing to further ensure public health and fortify brand reputations.”
Related Articles
-
The assay will be incorporated into assay into the methodology used by the USDA-FSIS Field Service Laboratories
-
The company received nine IMV ServiceTrak Clinical Laboratory Awards in the categories of Immunoassay, ID/AST and Blood Culture excellence.
-
FSIS expects that industry will see reduced product holding times while waiting for laboratory results.
-
Extensive molecular analysis finds substitutions, missing ingredients, hygienic issues and pathogens in burger products.
